Asian Pacific Journal of Cancer Prevention

Asian Pacific Journal of Cancer Prevention (아시아태평양암예방학회)
권호 표지
DOI QR코드

DOI QR Code

Roles of E-cadherin and Cyclooxygenase Enzymes in Predicting Different Survival Patterns of Optimally Cytoreduced Serous Ovarian Cancer Patients

  • Taskin, Salih (Department of Obstetrics and Gynecology, Ankara University School of Medicine) ;
  • Dunder, Ilkkan (Department of Obstetrics and Gynecology, Ankara University School of Medicine) ;
  • Erol, Ebru (Department of Pathology, Ankara University School of Medicine) ;
  • Taskin, Elif Aylin (Department of Obstetrics and Gynecology, Ankara University School of Medicine) ;
  • Kiremitci, Saba (Department of Pathology, Ankara University School of Medicine) ;
  • Oztuna, Derya (Department of Biostatistics, Ankara University School of Medicine) ;
  • Sertcelik, Ayse (Department of Pathology, Ankara University School of Medicine)
  • Published : 2012.11.30
Download PDF
⟨ Previous Next ⟩

Abstract

The relation between cyclooxygenase enzymes and E-cadherin, along with the roles of these markers in the prediction of survival in optimally cytoreduced serous ovarian cancer patients was investigated. Individuals who underwent primary staging surgery and achieved optimal cytoreduction (largest residual tumor volume <1 cm) constituted the study population. Specimens of 32 cases were immunohistochemically examined for cyclooxygenase-1, cyclooxygenase-2, and E-cadherin. Two could not be evaluated for E-cadherin and cyclooxygenase-1. Overall, 14/30, 19/30, and 15/32 cases were positive for E-cadherin, cyclooxygenase-1, and cyclooxygenase-2, respectively. The expressions of E-cadherin and cyclooxygenase-2 were inversely correlated (p:0.02). E-cadherin expression was related with favorable survival (p<0.001). The relation between the expression of cyclooxygenase enzymes and poor survival did not reach statistical significance. On multivariate analysis, E-cadherin appeared as an independent prognostic factor for survival. In conclusion, E-cadherin expression is strongly linked with favorable survival. E-cadherin and cyclooxygenase 2 may interact with each other during the carcinogenesis-invasion process. Further studies clarifying the relation between E-cadherin and cyclooxygenase enzymes may lead to new preventive and therapeutic targets in ovarian cancer.

Keywords

References

  1. Ali-Fehmi R, Morris RT, Bandyopadhyay S, et al (2005). Expression of cyclooxygenase-2 in advanced stage ovarian serous carcinoma: Correlation with tumor cell proliferation, apoptosis, angiogenesis, and survival. Am J Obstet Gynecol, 192, 819-25. https://doi.org/10.1016/j.ajog.2004.10.587
  2. Brouxhon S, Kyrkanides S, O'Banion MK, et al (2007). Sequential down-regulation of E-cadherin with squamous cell carcinoma progression: loss of E-cadherin via a prostaglandin E2-EP2 dependent posttranslational mechanism. Cancer Res, 15, 7654-64.
  3. Blechschmidt K, Sassen S, Schmalfeldt B, et al (2008). The E-cadherin repressor Snail is associated with lower overall survival of ovarian cancer patients. Br J Cancer, 98, 489-95. https://doi.org/10.1038/sj.bjc.6604115
  4. Chi DS, Liao JB, Leon LF, et al (2001). Identification of prognostic factors in advanced epithelial ovarian carcinoma. Gynecol Oncol, 82, 532-7. https://doi.org/10.1006/gyno.2001.6328
  5. Chen Q, Shinohara N, Abe T, et al (2004). Impact of cyclooxygenase-2 gene expression on tumor invasiveness in a human renal cell carcinoma cell line. J Urol, 172, 2153-7. https://doi.org/10.1097/01.ju.0000143440.08760.3a
  6. Chang YW, Marlin JW, Chance TW, et al (2006). RhoA mediates cyclooxygenase-2 signaling to disrupt the formation of adherens junctions and increase cell motility. Cancer Res, 66. 11700-8. https://doi.org/10.1158/0008-5472.CAN-06-1818
  7. Cho EY, Choi Y, Chae SW, et al (2006). Immunohistochemical study of the expression of adhesion molecules in ovarian serous neoplasms. Pathol Int, 56, 62-70. https://doi.org/10.1111/j.1440-1827.2006.01925.x
  8. Denkert C, Kobel M, Pest S, et al (2002). Expression of cyclooxygenase 2 is an independent prognostic factor in human ovarian carcinoma. Am J Pathol, 160, 893-903. https://doi.org/10.1016/S0002-9440(10)64912-7
  9. Dohadwala M, Yang SC, Luo J, et al (2006). Cyclooxygenase-2-dependent regulation of E-cadherin: prostaglandin E(2) induces transcriptional repressors ZEB1 and snail in nonsmall cell lung cancer. Cancer Res, 66, 5338-45. https://doi.org/10.1158/0008-5472.CAN-05-3635
  10. Erkinheimo TL, Lassus H, Finne P, et al (2004). Elevated cyclooxygenase-2 expression is associated with altered expression of p53 and SMAD4, amplification of HER 2/ neu, and poor outcome in serous ovarian carcinoma. Clin Cancer Res, 10, 538-45. https://doi.org/10.1158/1078-0432.CCR-0132-03
  11. Gupta RA, Tejada LV, Tong BJ, et al (2003). Cyclooxygenase-1 is overexpressed and promotes angiogenic growth factor production in ovarian cancer. Cancer Res, 63, 906-11.
  12. Faleiro-Rodrigues C, Macedo-Pinto I, Pereira D, et al (2004). Prognostic value of E-cadherin immunoexpression in patients with primary ovarian carcinomas. Ann Oncol, 15, 1535-42. https://doi.org/10.1093/annonc/mdh387
  13. Harris RE, Beebe-Donk J, Doss H, et al (2005). Aspirin, ibuprofen, and other nonsteroidal anti-inflammatory drugs in cancer prevention: a critical review of nonselective COX-2 blockade. Oncol Rep, 13, 559-83.
  14. Huang KJ, Sui LH (2012). The relevance and role of vascular endothelial growth factor C, matrix metalloproteinase-2 and E-cadherin in epithelial ovarian cancer. Med Oncol, 29, 318-23. https://doi.org/10.1007/s12032-010-9817-4
  15. Imai T, Horiuchi A, Wang C, et al (2003). Hypoxia attenuates the expression of E-cadherin via up-regulation of SNAIL in ovarian carcinoma cells. Am J Pathol, 163, 1437-47. https://doi.org/10.1016/S0002-9440(10)63501-8
  16. Jin HY, Feng YJ (2005). Inhibitory effects of antisense Snail on invasion and migration of ovarian carcinoma cells. Zhong Hua Fu Chan Ke Za Zhi, 40, 400-3.
  17. Jang TJ, Jeon KH, Jung KH (2009). Cyclooxygenase-2 expression is related to the epithelial-to-mesenchymal transition in human colon cancers. Yonsei Med J, 50, 818-24. https://doi.org/10.3349/ymj.2009.50.6.818
  18. Jin H, Yu Y, Zhangs T, et al (2010). Snail is critical for tumor growth and metastasis of ovarian carcinoma. Int J Cancer, 126, 2102-11.
  19. Jang TJ, Cha WH, Lee KS (2010). Reciprocal correlation between the expression of cyclooxygenase-2 and E-cadherin in human bladder transitional cell carcinomas. Virchows Arch, 457, 319-28. https://doi.org/10.1007/s00428-010-0943-3
  20. Lee JS, Choi YD, Lee JH, et al (2006). Expression of cyclooxygenase-2 in epithelial ovarian tumors and its relation to vascular endothelial growth factor and p53 expression. Int J Gynecol Cancer, 16, 247-53. https://doi.org/10.1111/j.1525-1438.2006.00477.x
  21. Li W, Wang J, Jiang HR, et al (2011). Combined Effects of Cyclooxygenase-1 and Cyclooxygenase-2 Selective Inhibitors on Ovarian Carcinoma in Vivo. Int J Mol Sci, 12, 668-81. https://doi.org/10.3390/ijms12010668
  22. Makarla PB, Saboorian MH, Ashfaq R, et al (2005). Promoter hypermethylation profile of ovarian epithelial neoplasms. Clin Cancer Res, 11, 5365-9. https://doi.org/10.1158/1078-0432.CCR-04-2455
  23. Menczer J (2009). Cox-2 expression in ovarian malignancies: A review of the clinical aspects. Eur J Obstet Gynecol Reprod Biol, 146, 129-32. https://doi.org/10.1016/j.ejogrb.2009.05.030
  24. Moody TW, Switzer C, Santana-Flores W, et al (2010). Dithiolethione modified valproate and diclofenac increase E-cadherin expression and decrease proliferation of nonsmall cell lung cancer cells. Lung Cancer, 68, 154-60. https://doi.org/10.1016/j.lungcan.2009.06.012
  25. Okamoto A, Shirakawa T, Bito T, et al (2008). Etodolac, a selective cyclooxygenase-2 inhibitor, induces upregulation of E-cadherin and has antitumor effect on human bladder cancer cells in vitro and in vivo. Urology, 71, 156-60. https://doi.org/10.1016/j.urology.2007.09.061
  26. Rathi A, Virmani AK, Schorge JO, et al (2002). Methylation profiles of sporadic ovarian tumors and nonmalignant ovaries from high-risk women. Clin Cancer Res, 8, 3324-31.
  27. Rao DS, Gui D, Koski ME, et al (2006). An inverse relation between COX-2 and E-cadherin expression correlates with aggressive histologic features in prostate cancer. Appl Immunohistochem Mol Morphol, 14, 375-83. https://doi.org/10.1097/01.pai.0000210417.61117.6c
  28. Sun WH, Zhu F, Chen GS, et al (2008). Blockade of cholecystokinin-2 receptor and cyclooxygenase-2 synergistically induces cell apoptosis, and inhibits the proliferation of human gastric cancer cells in vitro. Cancer Lett, 263, 302-11. https://doi.org/10.1016/j.canlet.2008.01.012
  29. Shim HS, Yoon BS, Cho NH (2009). Prognostic significance of paired epithelial cell adhesion molecule and E-cadherin in ovarian serous carcinoma. Hum Pathol, 40, 693-8. https://doi.org/10.1016/j.humpath.2008.10.013
  30. Uddin S, Ahmed M, Hussain A, et al (2010). Cyclooxygenase-2 inhibition inhibits PI3K/AKT kinase activity in epithelial ovarian cancer. Int J Cancer, 126, 382-94. https://doi.org/10.1002/ijc.24757
  31. Voutilainen KA, Anttila MA, Sillanpaa SM, et al (2006). Prognostic significance of E-cadherin-catenin complex in epithelial ovarian cancer. J Clin Pathol, 59, 460-7. https://doi.org/10.1136/jcp.2005.029876
  32. Yuecheng Y, Hongmei L, Xiaoyan X (2006). Clinical evaluation of E-cadherin expression and its regulation mechanism in epithelial ovarian cancer. Clin Exp Metastasis, 23, 65-74. https://doi.org/10.1007/s10585-006-9020-3
  33. Yoshida J, Horiuchi A, Kikuchi N, et al (2009). Changes in the expression of E-cadherin repressors, Snail, Slug, SIP1, and Twist, in the development and progression of ovarian carcinoma: the important role of Snail in ovarian tumorigenesis and progression. Med Mol Morphol, 42, 82-91. https://doi.org/10.1007/s00795-008-0436-5
  34. Wang Y, Sheng Q, Spillman MA, et al (2012). Gab2 regulates the migratory behaviors and E-cadherin expression via activation of the PI3K pathway in ovarian cancer cells. Oncogene, 31, 2512-20 https://doi.org/10.1038/onc.2011.435
  35. Zhou Y, Ran J, Tang C, et al (2007). Effect of celecoxib on E-cadherin, VEGF, Microvessel density and apoptosis in gastric cancer. Cancer Biol Ther, 6, 269-75.

Cited by

  1. AKT1 Inhibitory DNAzymes Inhibit Cell Proliferation and Migration of Thyroid Cancer Cells vol.14, pp.4, 2013, https://doi.org/10.7314/APJCP.2013.14.4.2571
  2. Roles of Signaling Pathways in the Epithelial-Mesenchymal Transition in Cancer vol.16, pp.15, 2015, https://doi.org/10.7314/APJCP.2015.16.15.6201
  3. Differential cyclooxygenase expression levels and survival associations in type I and type II ovarian tumors vol.11, pp.1, 2018, https://doi.org/10.1186/s13048-018-0389-9